CSCO
64
4
HRL
15
-11
CF
37
9
WY
8
-2
PFE
11
-2
CMCSA
44
2
MUR
42
3
MCK
66
-3
TGNA
42
-3
AMG
44
3
NRG
39
-5
LOW
52
6
MCHP
64
6
CAH
47
-7
EMN
39
3
HBI
36
3
NWSA
70
4
IVZ
35
2
PSA
35
5
STT
30
5
CSCO
64
4
HRL
15
-11
CF
37
9
WY
8
-2
PFE
11
-2
CMCSA
44
2
MUR
42
3
MCK
66
-3
TGNA
42
-3
AMG
44
3
NRG
39
-5
LOW
52
6
MCHP
64
6
CAH
47
-7
EMN
39
3
HBI
36
3
NWSA
70
4
IVZ
35
2
PSA
35
5
STT
30
5
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

This Could Be The Most Profitable 9 Minutes Of Your Life

See his program for yourself here.
Sell
44

REGN
Regeneron Pharmaceuticals

Last Price:
724.74
Seasonality Move:
8.4%

7 Day Trial

ALL ACCESS PASS

$ 7

[BREAKING] Pentagon to Spend Billions on "Living Missile"

Get the name of the company here >>>

Regeneron Pharmaceuticals Price Quote

$724.74
-0.31 (-0.04%)
(Updated: May 27, 2023 at 5:28 AM ET)

Regeneron Pharmaceuticals Key Stats

Sell
44
Regeneron Pharmaceuticals (REGN) is a Sell
Day range:
$719.00 - $726.77
52-week range:
$538.01 - $837.55
Dividend yield:
0%
P/E ratio:
18.97
P/S ratio:
6.67
P/B ratio:
3.39%
Volume:
742.5K
Avg. volume:
540.1K
1-year change:
6.09%
Market cap:
$79.5B
Revenue:
$12.2B
EPS:
$36.8

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.3B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.4B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.3B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 17.71%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 14.88%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 19.33%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Data Unavailable

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: -16.73% 5.55%
Revenue: 6.64% 5.48%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 883.78
Upside from Last Price: 21.89%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    172.1M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    1.8M REGN shares are owned by insiders